Standardizing Best Nursing Practice for Implanted Ports: Applying Evidence-based Professional Guidelines to Prevent Central Line-Associated Bloodstream Infections.

J Infus Nurs

Dana-Farber Cancer Institute, Boston, Massachusetts, and Brigham and Women's Hospital, Boston, Massachusetts. Susanne B. Conley, MSN, RN, CPON, AOCNS®, is an advanced oncology clinical nurse specialist at Dana-Farber Cancer Institute in Boston, Massachusetts, with more than 35 years of clinical, administrative, and educational experience. Ms Conley is responsible for oversight and development of nursing policies and procedures assuring compliance with current practice and regulatory agency requirements. As a clinical nurse specialist for several oncology specialty practices, she is responsible for assuring evidence-based practice and staff training. Ms Conley is active in national organizations and has served as a project team member for the Oncology Nursing Society Institute for Evidence-Based Practice Change. She has published articles and developed curricula on nursing practice, and has spoken extensively on nursing practice issues. Paula Buckley, BSN, RN, is an intravenous (IV) access nurse at Dana-Farber Cancer Institute in Boston. She serves on the venous access committee and precepts new RN staff with IV skills. Lisa Magarace, BSN, RN, is an IV and apheresis specialist and served for 2 years as the full-time charge nurse on the laboratory services unit at Dana-Farber Cancer Institute. Candace Hsieh, BSN, RN, CIC®, is an infection control nurse specialist. She works for the infection control department of both Brigham and Women's Hospital and Dana-Farber Cancer Institute, where she also works in the pediatric oncology department. She oversees surveillance and monitoring of central line-associated bloodstream infections. She also serves on the venous access, infection control, and nursing policy and procedure committees. Lillian Vitale Pedulla, MSN, BSN, RN, NEA-BC, served as the director of laboratory services, developing the nurse IV access team for Dana-Farber Cancer Institute. She served on the adult nursing practice, venous access, and nursing policy and procedure committees.

Published: August 2017

Nearly 3 million central vascular access devices (CVADs) are used in the United States each year. These devices are an important advance in health care and essential to oncology patients. However, CVADs are the most frequent cause of central line-associated bloodstream infections (CLABSIs). CLABSI can be prevented when evidence-based practices are followed consistently over time. Professional organizations establish valid standards and guidelines to guide CVAD practice. This article identifies strategies implemented at a comprehensive ambulatory cancer center to integrate professional evidence-based standards and guidelines for implanted port care into nursing practice at the point of care.

Download full-text PDF

Source
http://dx.doi.org/10.1097/NAN.0000000000000217DOI Listing

Publication Analysis

Top Keywords

nursing practice
8
central line-associated
8
line-associated bloodstream
8
bloodstream infections
8
standards guidelines
8
standardizing best
4
best nursing
4
practice implanted
4
implanted ports
4
ports applying
4

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!